Detalhe da pesquisa
1.
Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.
Oncologist
; 27(10): 839-848, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598205
2.
Targeting the ERß/HER Oncogenic Network in KRAS Mutant Lung Cancer Modulates the Tumor Microenvironment and Is Synergistic with Sequential Immunotherapy.
Int J Mol Sci
; 23(1)2021 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008514
3.
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.
Carcinogenesis
; 41(11): 1529-1542, 2020 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603404
4.
The Impact of Estrogen in the Tumor Microenvironment.
Adv Exp Med Biol
; 1277: 33-52, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119863
5.
Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence.
J Biol Chem
; 293(5): 1794-1809, 2018 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247004
6.
The Role of the Estrogen Pathway in the Tumor Microenvironment.
Int J Mol Sci
; 19(2)2018 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463044
7.
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
Cancer
; 123(15): 2936-2944, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28472537
8.
TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer.
Oncogene
; 43(19): 1431-1444, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485737
9.
Male sex and pretreatment weight loss are associated with poor outcome in patients with advanced non-small cell lung cancer treated with immunotherapy: a retrospective study.
Sci Rep
; 13(1): 17047, 2023 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813923
10.
Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.
Carcinogenesis
; 33(11): 2181-9, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22859269
11.
Estrogen Receptor ß in Cancer: To ß(e) or not to ß(e)?
Endocrinology
; 162(11)2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370841
12.
Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden.
JCI Insight
; 6(3)2021 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351788
13.
HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
Clin Cancer Res
; 15(11): 3740-50, 2009 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19470725
14.
Induction of Lung Tumors and Mutational Analysis in FVB/N Mice Treated with the Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone.
Methods Mol Biol
; 2102: 149-160, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31989553
15.
Influence of Estrogen on the NSCLC Microenvironment: A Comprehensive Picture and Clinical Implications.
Front Oncol
; 10: 137, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32133288
16.
Development of flow cytometry assays for measuring cell-membrane enzyme activity on individual cells.
J Cancer
; 11(3): 702-715, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31942194
17.
Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer.
Cancers (Basel)
; 12(6)2020 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32545260
18.
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
Lung Cancer
; 64(1): 51-9, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18701186
19.
Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.
Mol Cancer Ther
; 7(7): 1913-22, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18645002
20.
The estrogen pathway as a modulator of response to immunotherapy.
Immunotherapy
; 11(13): 1161-1176, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31361169